Vaccine candidate MVA-MERS-S (UniversitätsklinikumHamburg-Eppendorf)

N/A

Report date: 2022/08/29 20:00:24

Base Information

Drug NameVaccine candidate MVA-MERS-S (UniversitätsklinikumHamburg-Eppendorf)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMiddle East Respiratory Syndrome Coronavirus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversitätsklinikum Hamburg-Eppendorf
China Registration ClassN/A

Develop Information

Active CompaniesUniversitätsklinikum Hamburg-Eppendorf
Inactive CompaniesLudwig Maximilians University Of MunichPhilipps University Marburg Medical CenterCharite University, Berlin, Germany +[5] 
Active IndicationsMiddle East Respiratory Syndrome Coronavirus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A